These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1906915)

  • 1. Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Riera L; López Otin C; Ruibal A
    Int J Biol Markers; 1991; 6(1):31-2. PubMed ID: 1906915
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.
    Vizoso F; Allende MT; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum prolactin levels in women with gross cystic breast disease.
    Vizoso F; Allende MT; García-Muñiz JL; Alexandre E; Fueyo A; Ruibal A
    Int J Biol Markers; 1992; 7(4):225-9. PubMed ID: 1491178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin secretion in benign breast diseases.
    Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
    Gynecol Endocrinol; 1987 Jun; 1(2):195-200. PubMed ID: 3140581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
    Dogliotti L; Faggiuolo R; Ferusso A; Orlandi F; Sandrucci S; Tibo A; Angeli A
    Horm Res; 1985; 21(3):137-44. PubMed ID: 3922866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum prolactin level in patients with mastopathy. Clinical significance].
    Peters F; Breckwoldt M
    Verh Dtsch Ges Pathol; 1985; 69():401-4. PubMed ID: 3938116
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease.
    Allende MT; Vizoso F; Roiz MC; Fueyo A; Ruibal A
    Int J Biol Markers; 1990; 5(1):48-9. PubMed ID: 2230352
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
    Watt-Boolsen S; Eskildsen PC; Blaehr H
    Cancer; 1985 Aug; 56(3):500-2. PubMed ID: 4005811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GnRH-TRH stimulation tests in patients with mastopathy].
    Kasch R; Meissner J; Kunkel S
    Zentralbl Gynakol; 1988; 110(5):298-303. PubMed ID: 3131977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal steroids and tumor antigens in plasma and cyst fluid of women with gross cystic breast disease.
    Inaudi P; De Leo V; Baldini S; D'Antona N
    Ann N Y Acad Sci; 1990; 586():117-20. PubMed ID: 2356994
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correlation between the serum concentrations of BCM (breast cancer mucin), CA549 and estradiol in women with breast macrocysts].
    Vizoso F; Allende MT; Fueyo A; Ruibal A
    Med Clin (Barc); 1991 Feb; 96(5):198. PubMed ID: 2033998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations of serum concentrations of CA 15.3 and estradiol in women with breast macrocystic disease].
    Vizoso F; Allende MT; Fueyo A; Vivanco J
    Med Clin (Barc); 1990 May; 94(20):798. PubMed ID: 2392013
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between blood concentrations of CA 15.3 and estradiol in women with macrocystic disease of breast. Study in function of the type of cyst].
    Vizoso F; Allende MT; Díez MC; Ruibal A
    Rev Clin Esp; 1991 Nov; 189(8):390-1. PubMed ID: 1784805
    [No Abstract]   [Full Text] [Related]  

  • 19. CA 15.3 behaviour in cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Vigal G; García-Morán M; Ruibal A
    Int J Biol Markers; 1989; 4(3):181-2. PubMed ID: 2614087
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
    Boyd AE; Sanchez-Franco F
    J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.